insights_auto
Why is ORX down 23,39%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
1,05 SEK
arrow_downward
-23,39%(-0,32) 1D
9 қар., 17:29:41 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
1,03 SEK
High
1,25 SEK
Low
0,99 SEK
Mkt. cap
36,76 млн
Avg. vol.
337,59 м.
Volume
1,28 млн
P/E ratio
0,05
52-wk high
36,00 SEK
52-wk low
0,99 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
Open
1,03 SEK
High
1,25 SEK
Low
0,99 SEK
Mkt. cap
36,76 млн
Avg. vol.
337,59 м.
Volume
1,28 млн
P/E ratio
0,05
52-wk high
36,00 SEK
52-wk low
0,99 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
New York Post
·
56 минут бұрын
Dow surges 1,000 points after last week’s historic tech rout, while Jensen Huang’s Nvidia slumps
TradingView
·
51 минут бұрын
Avalanche: Secures clearing and settlement role for NYSE-affiliated platform - 09 Nov 2026
Dealroom
·
25 минут бұрын
Windward Bio targets $1B valuation in Nasdaq IPO
Yahoo Finance
·
1 сағат бұрын
S&P 500 Just Wiped Out $3 Trillion: Why This 0.35-Beta Stock is a Safe Haven
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com